Modulation of Tyrosine Kinase Activity Has Multiple Actions on Insulin Release from the Pancreatic β : Cell: Studies with Lavendustin A

Access this Article

Author(s)

Abstract

We investigated the role of tyrosine kinases in the regulation of insulin release from a hamster β-cell line, HIT T15, using selective tyrosine kinase inhibitors. Genistein increased the insulin release induced by glucose, but herbimycin A, tyrphostins and the erbstatin analogue failed to change the release. Lavendustin A at 0.1 nM -1 μM caused a concave-shaped inhibition of the insulin release stimulated by 7 mM glucose. The inhibitory effect of lavendustin A was overcome by higher concentrations of glucose. Lavendustin B, the negative control analogue, had no effect on the release. Lavendustin A at a nanomolar range progressively inhibited insulin release by high K<SUP>+</SUP> (50 mM)-depolarization, whereas the inhibitor did not change the insulin release by Ca<SUP>2+</SUP> ionophore (A23187). On the contrary, lavendustin A at 10 nM significantly increased insulin release when glucose-induced insulin release was enhanced by either 5 μM forskolin or 162 nM 12-Ο-tetradecanoylphorbol 13-acetate. Lavendustin A failed to influence the Ca<SUP>2+</SUP>-induced insulin release from HIT cells permeabilized with streptolysin-Ο. These findings suggest that tyrosine kinases may play versatile roles in the control of insulin release from the pancreatic β-cell.

Journal

  • The Japanese Journal of Pharmacology

    The Japanese Journal of Pharmacology 74(2), 203-208, 1997-06-01

    The Japanese Pharmacological Society

References:  30

Codes

  • NII Article ID (NAID)
    10008679009
  • NII NACSIS-CAT ID (NCID)
    AA00691188
  • Text Lang
    ENG
  • Article Type
    ART
  • ISSN
    00215198
  • NDL Article ID
    4260350
  • NDL Source Classification
    ZS51(科学技術--薬学)
  • NDL Call No.
    Z53-D199
  • Data Source
    CJP  NDL  J-STAGE 
Page Top